Cargando…
Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temp...
Autores principales: | Patel, B. Divyakant, Modi, R. Valay, Thakkar, N. Alok, Patel, A. Arpita, Thakkar, P. Hetal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467810/ https://www.ncbi.nlm.nih.gov/pubmed/23066188 http://dx.doi.org/10.4103/0975-7406.94121 |
Ejemplares similares
-
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system
por: Thakkar, Hetal, et al.
Publicado: (2011) -
Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
por: Thakkar, Hetal Paresh, et al.
Publicado: (2011) -
Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability
por: Kushwaha, Anand Kumar, et al.
Publicado: (2013) -
Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020) -
Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
por: Du, Xinhui, et al.
Publicado: (2021)